Triple-Negative Breast Cancer (TNBC) Active Not Recruiting Phase 2 Trials for Veliparib (DB07232)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01818063Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast CancerTreatment